The molecular biology core seeks to provide center investigators with [1] a centralized resource for oligodeoxynucleotide synthesis, chiefly to facilitate the acquisition of primers for use in polymerase chain reaction amplification, sequencing, and mutagenesis, [2] a library of useful primers, already made and characterized for these purpose, [3] centralized access to a library of useful plasmid constructs, for use in cloning, eukaryotic selection, expression, reporting, and use as reference and control agents, including many proviral plasmids, [4] a central reference resource for quantitation of viral RNA and DNA, including a central reference QC-PCR facility, supplying primers, constructs, and reference reagents and samples, as well as performing assays as a service, and [5] a central data acquisition and sharing of sequence information. In order to accomplish these goals the core proposes: [1] to utilize a dedicated synthesizer for the preparation of oligonucleotides, [2] to perform purification of synthesized oligonucleotides by polyacrylamide gel electrophoresis, [3] to synthesize frequently used primers on a large scale, aliquoting and dispensing these with quality controls, [4] to supply the data analysis core primer information, for dissemination to center investigators, [5] to perform the transformation, preparation and purification of a variety of frequently used plasmids as well as performing custom plasmid preparation on a recharge basis, [6] to maintain secure bacterial and plasmid stocks for center investigators, [7] to perform QC-PCR for genomic and spliced HIV-1 and HIV-2 messages and DNA PCR for provirus with internal standards, providing primers and plasmid constructs for QC-PCR to center investigators, participating in the custom design of QC-PCR systems, as well as standardized samples, samples, and standardized RNA and DNA preparations, on a recharge basis, and [8] sequencing of PCR products for analysis of HIV genomes, on a recharge basis when exceeding funded capability.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI036214-01
Application #
3747625
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Rhodes, Tim (2018) The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential. Soc Sci Med 201:71-79
Morales, Mario; Rafful, Claudia; Gaines, Tommi L et al. (2018) Factors associated with extrajudicial arrest for syringe possession: results of a department-wide survey of municipal police in Tijuana, Mexico. BMC Int Health Hum Rights 18:36
Ben Hamida, Amen; Rafful, Claudia; Jain, Sonia et al. (2018) Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico. J Urban Health 95:83-90
Christensen-Quick, Aaron; Chaillon, Antoine; Yek, Christina et al. (2018) Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy. J Acquir Immune Defic Syndr 79:e104-e107
Groessl, Erik J; Ganiats, Theodore G; Hillery, Naomi et al. (2018) Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis 18:102
Dillon, Stephanie M; Guo, Kejun; Austin, Gregory L et al. (2018) A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis. AIDS 32:1599-1611
Goldenberg, Shira M; Rocha Jiménez, Teresita; Brouwer, Kimberly C et al. (2018) Influence of indoor work environments on health, safety, and human rights among migrant sex workers at the Guatemala-Mexico Border: a call for occupational health and safety interventions. BMC Int Health Hum Rights 18:9
Mehta, Sanjay R; Chaillon, Antoine; Gaines, Tommi L et al. (2018) Impact of Public Safety Policies on Human Immunodeficiency Virus Transmission Dynamics in Tijuana, Mexico. Clin Infect Dis 66:758-764
Dinesha, T R; Boobalan, J; Sivamalar, S et al. (2018) Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV. J Viral Hepat 25:718-723
Fraser, Hannah; Zibbell, Jon; Hoerger, Thomas et al. (2018) Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction 113:173-182

Showing the most recent 10 out of 921 publications